TM9SF1
Transmembrane 9 superfamily member 1
Also known as: HMP70, MP70, TM9S1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15321
- Gene
- TM9SF1
- Ensembl
- ENSG00000100926
- Chromosome
- 14
- Canonical length
- 606 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Predicted to be involved in protein localization to membrane. Predicted to be located in autophagosome membrane; cytoplasmic vesicle; and lysosomal membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
606 residues, UniProt reviewed canonical sequence.
>O15321|TM9SF1
1 MTVVGNPRSW SCQWLPILIL LLGTGHGPGV EGVTHYKAGD PVILYVNKVG PYHNPQETYH
61 YYQLPVCCPE KIRHKSLSLG EVLDGDRMAE SLYEIRFREN VEKRILCHMQ LSSAQVEQLR
121 QAIEELYYFE FVVDDLPIRG FVGYMEESGF LPHSHKIGLW THLDFHLEFH GDRIIFANVS
181 VRDVKPHSLD GLRPDEFLGL THTYSVRWSE TSVERRSDRR RGDDGGFFPR TLEIHWLSII
241 NSMVLVFLLV GFVAVILMRV LRNDLARYNL DEETTSAGSG DDFDQGDNGW KIIHTDVFRF
301 PPYRGLLCAV LGVGAQFLAL GTGIIVMALL GMFNVHRHGA INSAAILLYA LTCCISGYVS
361 SHFYRQIGGE RWVWNIILTT SLFSVPFFLT WSVVNSVHWA NGSTQALPAT TILLLLTVWL
421 LVGFPLTVIG GIFGKNNASP FDAPCRTKNI AREIPPQPWY KSTVIHMTVG GFLPFSAISV
481 ELYYIFATVW GREQYTLYGI LFFVFAILLS VGACISIALT YFQLSGEDYR WWWRSVLSVG
541 STGLFIFLYS VFYYARRSNM SGAVQTVEFF GYSLLTGYVF FLMLGTISFF SSLKFIRYIY
601 VNLKMDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TM9SF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 54 nTPM
- salivary gland: 40 nTPM
- adrenal gland: 40 nTPM
- liver: 37 nTPM
- choroid plexus: 35 nTPM
- parathyroid gland: 34 nTPM
Single-cell type
- ependymal cells: 25 nCPM
- bergmann glia: 16 nCPM
- astrocytes: 13 nCPM
- oligodendrocyte progenitor cells: 12 nCPM
- oligodendrocytes: 12 nCPM
- other brain neurons: 10 nCPM
Immune cell
- plasmacytoid DC: 39 nTPM
- basophil: 33 nTPM
- neutrophil: 28 nTPM
- eosinophil: 25 nTPM
- myeloid DC: 23 nTPM
- NK-cell: 23 nTPM
Brain region
- choroid plexus: 31 nTPM
- midbrain: 12 nTPM
- medulla oblongata: 11 nTPM
- spinal cord: 10 nTPM
- thalamus: 10 nTPM
- white matter: 9.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.11
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TM9SF1 as an antibody target. Whether an autoantibody or antibody against TM9SF1 could matter depends on whether native TM9SF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TM9SF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TM9SF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...